Related references
Note: Only part of the references are listed.Multiple BCL2 mutations cooccurring with Gly101Val emerge in chronic lymphocytic leukemia progression on venetoclax
Piers Blombery et al.
BLOOD (2020)
Changes in Bcl-2 members after ibrutinib or venetoclax uncover functional hierarchy in determining resistance to venetoclax in CLL
Marco Haselager et al.
BLOOD (2020)
Venetoclax and Obinutuzumab in Patients with CLL and Coexisting Conditions
K. Fischer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Dissection of the Effects of JAK and BTK Inhibitors on the Functionality of Healthy and Malignant Lymphocytes
Tom Hofland et al.
JOURNAL OF IMMUNOLOGY (2019)
Venetoclax-Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia
J. F. Seymour et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Targeting antigen-independent proliferation in chronic lymphocytic leukemia through differential kinase inhibition
E. Slinger et al.
LEUKEMIA (2017)
JASPAR 2016: a major expansion and update of the open-access database of transcription factor binding profiles
Anthony Mathelier et al.
NUCLEIC ACIDS RESEARCH (2016)
Activity of the Janus kinase inhibitor ruxolitinib in chronic lymphocytic leukemia: results of a phase II trial
David E. Spaner et al.
HAEMATOLOGICA (2016)
Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia
Andrew W. Roberts et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
STAT3 and NF-κB cooperatively control in vitro spontaneous apoptosis and poor chemo-responsiveness in patients with chronic lymphocytic leukemia
Feng-Ting Liu et al.
ONCOTARGET (2016)
Activity of the Janus kinase inhibitor ruxolitinib in chronic lymphocytic leukemia: results of a phase II trial
David E. Spaner et al.
HAEMATOLOGICA (2016)
Resistance to ABT-199 induced by microenvironmental signals in chronic iymphocytic leukemia can be counteracted by CD20 antibodies or kinase inhibitors
Rachel Thijssen et al.
HAEMATOLOGICA (2015)
Resistance to ABT-199 induced by microenvironmental signals in chronic iymphocytic leukemia can be counteracted by CD20 antibodies or kinase inhibitors
Rachel Thijssen et al.
HAEMATOLOGICA (2015)
Enhancement of CD154/IL4 proliferation by the T follicular helper (Tfh) cytokine, IL21 and increased numbers of circulating cells resembling Tfh cells in chronic lymphocytic leukaemia
Matthew J. Ahearne et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Therapeutic modulators of STAT signalling for human diseases
Gabriella Miklossy et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Crosstalk in NF-κB signaling pathways
Andrea Oeckinghaus et al.
NATURE IMMUNOLOGY (2011)
Dichotomy in NF-κB signaling and chemoresistance in immunoglobulin variable heavy-chain-mutated versus unmutated CLL cells upon CD40/TLR9 triggering
J. M. Tromp et al.
ONCOGENE (2010)
A signal network involving coactivated NF-κB and STAT3 and altered p53 modulates BAX/BCL-XL expression and promotes cell survival of head and neck squamous cell carcinomas
Tin Lap Lee et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
IL-4-stimulated NF-κB activity is required for Stat6 DNA binding
Vivian T. Thieu et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
Unphosphorylated STAT3 accumulates in response to IL-6 and activates transcription by binding to NF kappa B
Jinbo Yang et al.
GENES & DEVELOPMENT (2007)
The JAK-STAT signaling pathway: Input and output intergration
Peter J. Murray
JOURNAL OF IMMUNOLOGY (2007)
IκBε provides negative feedback to control NF-κB oscillations, signaling dynamics, and inflammatory gene expression
Jeffrey D. Kearns et al.
JOURNAL OF CELL BIOLOGY (2006)
Phosphorylation of RelA/p65 on serine 536 defines an IκBα-independent NF-κB pathway
CY Sasaki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Activation of dendritic cells via inhibition of Jak2/STAT3 signaling
Y Nefedova et al.
JOURNAL OF IMMUNOLOGY (2005)
Human T-cell lymphotropic virus type 1 tax induction of biologically active NF-κB requires IκB kinase-1-mediated phosphorylation of RelA/p65
AM O'Mahony et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Interleukin 1 activates STAT3/nuclear factor-κB cross-talk via a unique TRAF6-and p65-dependent mechanism
Y Yoshida et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Regulation of the NF-κB-inducing kinase by tumor necrosis factor receptor-associated factor 3-induced degradation
GX Liao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Expression profiling via novel multiplex assay allows rapid assessment of gene regulation in defined signalling pathways
E Eldering et al.
NUCLEIC ACIDS RESEARCH (2003)
IKKβ plays an essential role in the phosphorylation of RelA/p65 on serine 536 induced by lipopolysaccharide
F Yang et al.
JOURNAL OF IMMUNOLOGY (2003)
The NF-κB activation in lymphotoxin β receptor signaling depends on the phosphorylation of p65 at serine 536
X Jiang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
IKKβ and phosphatidylinositol 3-kinase/Akt participate in non-pathogenic gram-negative enteric bacteria-induced RelA phosphorylation and NF-κB activation in both primary and intestinal epithelial cell lines
D Haller et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
NF-κB-inducing kinase regulates the processing of NF-κB2 p100
GT Xiao et al.
MOLECULAR CELL (2001)
Share Paper
